182 related articles for article (PubMed ID: 30789856)
1. Ilaprazole Compared With Rabeprazole in the Treatment of Duodenal Ulcer: A Randomized, Double-blind, Active-controlled, Multicenter Study.
Fan L; Xianghong Q; Ling W; Ying H; Jielai X; Haitang H
J Clin Gastroenterol; 2019 Oct; 53(9):641-647. PubMed ID: 30789856
[TBL] [Abstract][Full Text] [Related]
2. Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
Ho KY; Kuan A; Zaño F; Goh KL; Mahachai V; Kim DY; Yoon HM
J Gastroenterol; 2009; 44(7):697-707. PubMed ID: 19434360
[TBL] [Abstract][Full Text] [Related]
3. Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
Wang L; Zhou L; Hu H; Lin S; Xia J
Curr Med Res Opin; 2012 Jan; 28(1):101-9. PubMed ID: 22070512
[TBL] [Abstract][Full Text] [Related]
4. Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study.
Bang CS; Shin WG; Seo SI; Choi MH; Jang HJ; Park SW; Kae SH; Yang YJ; Shin SP; Baik GH; Kim HY
Surg Endosc; 2019 May; 33(5):1376-1385. PubMed ID: 30167954
[TBL] [Abstract][Full Text] [Related]
5. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
Wang L; Zhou L; Lin S; Hu H; Xia J
J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
[TBL] [Abstract][Full Text] [Related]
6. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Breiter JR; Riff D; Humphries TJ
Am J Gastroenterol; 2000 Apr; 95(4):936-42. PubMed ID: 10763941
[TBL] [Abstract][Full Text] [Related]
7. Ilaprazole: Is this a superior proton pump inhibitor for duodenal ulcer?
Bohidar NP; Krishna K; Panda BK; Patel C
Trop Gastroenterol; 2013; 34(2):95-8. PubMed ID: 24377157
[TBL] [Abstract][Full Text] [Related]
8. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.
Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
Aliment Pharmacol Ther; 1999 Feb; 13(2):179-86. PubMed ID: 10102948
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].
Zhou LY; Lin SR; Yang YS; Zhang ST; Yuan YZ; Shi RH; Hou XH; Xia JL; Hu HT; Qin XH
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):290-2. PubMed ID: 20627032
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.
Ji XQ; Du JF; Chen G; Chen G; Yu B
World J Gastroenterol; 2014 May; 20(17):5119-23. PubMed ID: 24803828
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control.
Wang H; Shao F; Liu X; Xu W; Ou N; Qin X; Liu F; Hou X; Hu H; Jiang J
Br J Clin Pharmacol; 2019 Nov; 85(11):2547-2558. PubMed ID: 31332820
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
[TBL] [Abstract][Full Text] [Related]
14. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
Cloud ML; Enas N; Humphries TJ; Bassion S
Dig Dis Sci; 1998 May; 43(5):993-1000. PubMed ID: 9590413
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study.
Shin JS; Lee JY; Cho KH; Park HL; Kukulka M; Wu JT; Kim DY; Park SH
Aliment Pharmacol Ther; 2014 Sep; 40(5):548-61. PubMed ID: 25041486
[TBL] [Abstract][Full Text] [Related]
16. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study.
Dai WQ; Zhou YQ; Xu L; Wang BF; Fan XM; Wu JY; Wang CY; Xu XF; Guo CY
Hepatogastroenterology; 2012; 59(113):296-9. PubMed ID: 22260837
[TBL] [Abstract][Full Text] [Related]
17. Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study.
Zhu H; Pan X; Zhang L; Sun H; Fan H; Pan Z; Huang C; Shi Z; Ding J; Wang Q; Du Y; Lyu N; Li Z
Chin Med J (Engl); 2022 Dec; 135(24):2941-2949. PubMed ID: 36580650
[TBL] [Abstract][Full Text] [Related]
18. Ten mg dexrabeprazole daily is as effective as 20 mg rabeprazole daily.
Kanakia R; Jain S
World J Gastroenterol; 2008 Jul; 14(28):4586-7. PubMed ID: 18680246
[TBL] [Abstract][Full Text] [Related]
19. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of efficacy, safety and tolerability rabeprazole in treatment of acid-peptic diseases ].
de Freitas JA; Lima LM; Ranieri JL; Olivieri JC; Fragoso HJ; Chinzon D
Arq Gastroenterol; 2002; 39(1):60-5. PubMed ID: 12184168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
